VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $753,270 | -56.5% | 23,285 | -61.5% | 0.37% | -52.5% |
| Q4 2022 | $1,732,996 | -41.7% | 60,467 | -22.0% | 0.79% | -16.1% |
| Q1 2022 | $2,974,000 | +1856.6% | 77,541 | +1536.6% | 0.94% | +1300.0% |
| Q4 2021 | $152,000 | -38.7% | 4,738 | -35.1% | 0.07% | -41.2% |
| Q2 2021 | $248,000 | +7.4% | 7,299 | -3.7% | 0.11% | -2.6% |
| Q1 2021 | $231,000 | -29.8% | 7,583 | -16.9% | 0.12% | -33.5% |
| Q4 2020 | $329,000 | +10.8% | 9,123 | +20.2% | 0.18% | -11.1% |
| Q3 2020 | $297,000 | -49.3% | 7,591 | -52.5% | 0.20% | -44.5% |
| Q2 2020 | $586,000 | +91.5% | 15,986 | +39.4% | 0.36% | +164.4% |
| Q3 2019 | $306,000 | – | 11,470 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |